Leena Gandhi
Direktor/Vorstandsmitglied bei NEXIMMUNE, INC.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kristi Jones | F | 60 | 7 Jahre | |
| Detlev Biniszkiewicz | M | 56 |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | 6 Jahre |
| Alan Roemer | M | 54 | 7 Jahre | |
| Stephen Curtis | M | - |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | - |
| Mathias Oelke | M | 56 | 13 Jahre | |
| Fredrik Wiklund | M | 53 |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | - |
| Paul D'Angio | M | 65 | 7 Jahre | |
| Karen Walker | F | 62 | 6 Jahre | |
| Zheng Bin Yao | M | 58 | 7 Jahre | |
| Vijaya R. Pattabiraman | M | - |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | - |
| Anat Hakim | F | 54 | 4 Jahre | |
| Sol Barer | M | 76 | 5 Jahre | |
| Grant Verstandig | M | 34 | 3 Jahre | |
| Tim Bertram | M | 68 | 7 Jahre | |
| Warren E. Pickett | M | 75 |
University of California, Berkeley
| 27 Jahre |
| Alexander Mayweg | M | 49 |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | 7 Jahre |
| Chad Rubin | M | - | 3 Jahre | |
| Michael Rosenzweig | M | - |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | - |
| Tonya Catterton | F | - | - | |
| Devin Quinlan | M | - |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | 1 Jahre |
| Joshua Resnick | M | 49 |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | - |
| Max Starkov | M | - |
New York University
| 23 Jahre |
| Ivan Cheung | M | 47 |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | - |
| Jacob Chacko | M | 45 |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | 3 Jahre |
| Axel Hoos | M | 54 |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | 1 Jahre |
| Matthew Schiller | M | - | 3 Jahre | |
| Thomas Woiwode | M | 52 |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | 6 Jahre |
| Christine Siu | F | 47 |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | - |
| Matt Roden | M | 53 |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | - |
| Lana Dubovik | F | - |
New York University
| 22 Jahre |
| Laura Shawver | M | 66 |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | - |
| Evangelos Simoudis | M | - |
New York University
| 6 Jahre |
| Karen Haslbeck | F | - | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ellen Marram | F | 77 | 17 Jahre | |
| Cheryl Mills | F | 59 |
New York University
| 7 Jahre |
| Pablo Mitchell | M | - |
University of California, Berkeley
| 5 Jahre |
| Bambang Susantono | M | 60 |
University of California, Berkeley
| 5 Jahre |
| Ilan Gur | M | - |
University of California, Berkeley
| 8 Jahre |
| Susan Mahony | M | 59 | 18 Jahre | |
| Jen L. Neumann | F | - |
University of California, Berkeley
| 4 Jahre |
| Tim Stover | M | - | 3 Jahre | |
| Matthew Steiner | M | - |
New York University
University of California, Berkeley
| 7 Jahre |
| John Windover | M | - |
University of California, Berkeley
| 5 Jahre |
| Nickhil Jakatdar | M | - |
University of California, Berkeley
| 4 Jahre |
| John Beczak | M | - |
New York University
| 3 Jahre |
| Jesse Jit Singh | M | - |
New York University
University of California, Berkeley
| 7 Jahre |
| Metta Margaretha Murdaya | F | 50 |
New York University
University of California, Berkeley
| 7 Jahre |
| Alan Williams | M | - |
University of California, Berkeley
| 8 Jahre |
| Michael Harrington | M | 61 | 29 Jahre | |
| Andrew J. Euretig | M | - |
University of California, Berkeley
| 10 Jahre |
| Julia G. Butchko | M | 53 | - | |
| Matthew A. O'Hara | M | - |
University of California, Berkeley
| 3 Jahre |
| Liran Amrany | M | - |
University of California, Berkeley
| 6 Jahre |
| Ajar Ashyrkulova | M | - |
New York University
| 5 Jahre |
| Yi Ma | M | 51 |
University of California, Berkeley
| 4 Jahre |
| Amit Mehrotra | M | - |
University of California, Berkeley
| 4 Jahre |
| Laura A. Smoliar | M | - |
University of California, Berkeley
| 4 Jahre |
| Thomas Pistor | M | 52 |
University of California, Berkeley
| 5 Jahre |
| Charles J. Bair | M | - |
University of California, Berkeley
| 5 Jahre |
| Pamela Kaufman | F | - |
New York University
| 4 Jahre |
| Andy Jagoe | M | - |
University of California, Berkeley
| 3 Jahre |
| Ahmed Alamin | M | - |
New York University
University of California, Berkeley
| 7 Jahre |
| Gregory M. Heywood | M | 59 |
University of California, Berkeley
| 12 Jahre |
| Amir Nashat | M | 51 |
University of California, Berkeley
| 6 Jahre |
| Amit Narayan | M | - |
University of California, Berkeley
| 4 Jahre |
| Greg Chang | M | 44 |
University of California, Berkeley
| 4 Jahre |
| Derrick Lee | M | - |
University of California, Berkeley
| 4 Jahre |
| Kian Wee Lim | M | 44 |
New York University
| 4 Jahre |
| J. Lavia Thomas | M | - |
University of California, Berkeley
| 4 Jahre |
| Heather Brien | F | - |
University of California, Berkeley
| 3 Jahre |
| Rafael Irizarry | M | - |
University of California, Berkeley
| 5 Jahre |
| Suraj Panjwani | M | - |
New York University
| 3 Jahre |
| Robby Flannery | M | - |
University of California, Berkeley
| 5 Jahre |
| Jenny Sohn | F | - |
University of California, Berkeley
| 4 Jahre |
| Ju-Hyun Kim | M | 62 |
University of California, Berkeley
| 2 Jahre |
| Michael French | M | - |
University of California, Berkeley
| 4 Jahre |
| Xiu Lan Zhang | M | 61 |
University of California, Berkeley
| 3 Jahre |
| Jen Tennant | M | - |
University of California, Berkeley
| 4 Jahre |
| Anne Friedlander | M | - |
University of California, Berkeley
| 7 Jahre |
| Francis Sarena | M | 53 |
University of California, Berkeley
| 3 Jahre |
| Kai-Yan Lee | M | 47 |
University of California, Berkeley
| 4 Jahre |
| Heather Fernandez | F | 48 |
University of California, Berkeley
| 5 Jahre |
| Laura Tyson | M | 76 |
University of California, Berkeley
| 19 Jahre |
| Peter G. Schultz | M | 67 |
University of California, Berkeley
| 13 Jahre |
| Andrew Hendley | M | - |
University of California, Berkeley
| 4 Jahre |
| Raj Mahajan | M | - |
University of California, Berkeley
| 4 Jahre |
| Julie Bell | F | - |
University of California, Berkeley
| 3 Jahre |
| John Meza | M | - |
University of California, Berkeley
| 4 Jahre |
| David Danielson | M | - |
University of California, Berkeley
| 6 Jahre |
| Yuan Da Zhang | M | - |
University of California, Berkeley
| 4 Jahre |
| Arif Fazal | M | - |
University of California, Berkeley
| - |
| Ramin Hojati | M | - |
University of California, Berkeley
| 3 Jahre |
| Jason Ciaglo | M | - |
University of California, Berkeley
| 4 Jahre |
| Donald Thrasher | M | 53 |
University of California, Berkeley
| 4 Jahre |
| Uri Lopatin | M | 52 |
New York University
| 2 Jahre |
| Ben Chakir | M | - |
New York University
| 4 Jahre |
| August Rose Fern | F | - |
University of California, Berkeley
| 5 Jahre |
| Darren Scott Cockburn | M | 55 |
University of California, Berkeley
| 2 Jahre |
| Da Qing Cai | M | 59 |
University of California, Berkeley
| 4 Jahre |
| mukundh nair | M | - |
New York University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Leena Gandhi
- Persönliches Netzwerk